Stock Track | Cellebrite Plunges 6.36% in Pre-market as Q1 Net Income Misses Estimates

Stock Track05-14

Cellebrite's stock fell 6.36% in pre-market trading on Thursday following the release of its first-quarter 2026 financial results.

The digital intelligence company reported quarterly revenue of $128.301 million, slightly above analyst estimates of $126.8 million. Adjusted EBITDA also beat expectations, coming in at $30.617 million versus the $27.2 million estimate. However, the company's net income of $10.938 million significantly missed the Ibes estimate of $23.9 million, which appears to be the primary driver behind the stock's decline.

For the second quarter, Cellebrite provided an outlook for revenue between $130 million and $133 million, and adjusted EBITDA between $29 million and $31 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment